Thermo Fisher Scientific Agrees with Affymetrix that Merger Agreement Remains Superior
March 28, 2016
WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, issued the following statement regarding Affymetrix, Inc.’s (NASDAQ: AFFX) press release dated March 28, 2016: JP Morgan is acting as financial advisor to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel.“We are pleased that the [...]
March 25, 2016
Munich, Germany, - ibidi extends its existing product range for classic immunofluorescence experiments that use standard coverslip techniques. The new 3 well and 8 well removable cultivation chambers, in addition to the 12 well product, consist of a self-adhesive silicone gasket mounted on a standard glass slide. Users benefit from various growth areas and small [...]
March 24, 2016
Newcastle upon Tyne, UK - Ground-breaking new sample collection and preparation technologies which could enable simple and effective tuberculosis (TB) testing in the community, helping to reach the 3 million patients missed by healthcare systems each year, have been developed by life sciences tools and technologies developer QuantuMDx and leading academic institute St George’s, University [...]
MTS ANNOUNCES EXPANDED SERVICE CAPABILITIES IN EUROPE
March 24, 2016
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and position sensors, announced the expansion of Test Services capabilities in its Berlin facility. This expansion was driven by growing customer demand in Europe, which not only represents a meaningful portion of the installed base of MTS test [...]
VIROCYT® ANNOUNCES A PARADIGM SHIFT IN INFLUENZA VIRUS QUANTIFICATION: VIROTAG® INVX
March 24, 2016
BROOMFIELD, CO – ViroCyt®, the leader in rapid virus quantification, announced that it has developed and launched an antibody-based detection system for influenza capable of determining virus titer for both flu A and flu B during a one minute analysis. Every year, the flu virus causes millions of cases of illness and hundreds of thousands [...]
Meridian Bioscience Acquires Magellan Diagnostics, Inc.
March 24, 2016
CINCINNATI, - Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) announced that it has completed the acquisition of Magellan Biosciences, Inc. and its wholly owned subsidiary Magellan Diagnostics, Inc. Headquartered in Billerica, Massachusetts (near Boston), Magellan pioneered the engineering, development and manufacturing of FDA-cleared products for the testing of blood to diagnose lead poisoning in children and [...]
AMSBIO Launches Primary Human Cancer Cell Range
March 24, 2016
AMSBIO announces an extensive range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate. Despite significant advances in cancer research and treatments, the eradication of the disease remains elusive. This has led to a more urgent focus on precision medicine and advanced treatments like immunotherapy and the [...]
March 23, 2016
SANTA CLARA, Calif. - Affymetrix, Inc. (NASDAQ:AFFX, “Affymetrix” or the “Company”) announced that the Company’s Board of Directors, in consultation with its legal and financial advisors, has determined that the new unsolicited merger proposal submitted by Origin Technologies Corporation, LLC (“Origin”) on March 22, 2016, could reasonably be expected to lead to a Superior Proposal, [...]
BINDER launches a new CO2 incubator on the market
March 23, 2016
Tuttlingen, Germany – CO2 incubators have a fundamental role to play whenever cell cultures are involved in scientific, medical, and even industrial research laboratories. BINDER GmbH, the world's largest specialist in simulation chambers for scientific and industrial laboratories, has designed a unit for all standard applications in cell culture laboratories in the form of the [...]
Affymetrix to Engage in Discussions With Origin Technologies
March 23, 2016
SANTA CLARA, Calif. - Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or the “Company”) announced that the Company’s Board of Directors has informed Origin Technologies Corporation, LLC (“Origin”) that the Company will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire the Company for $17.00 per share in an [...]
